US 12070509
Nucleic acids and methods of treatment for cystic fibrosis
granted A61KA61K48/0033A61K48/0041
Quick answer
US patent 12070509 (Nucleic acids and methods of treatment for cystic fibrosis) held by ARCTURUS THERAPEUTICS, INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K48/0033, A61K48/0041, A61K48/005, A61K9/0043